Weight Management

Thirty years ago, when I began studying protein metabolism, I would never have guessed that 2025 would be spent explaining why more protein is not always better.

Two pharmacists pursue different paths to make weight-management a key part of their practice.

New study provides contemporary data on the frequency of glucagon-like peptide 1 receptor agonist use for postpartum weight reduction.

Paradoxically, bariatric surgery is sometimes responsible for the development of new pathologies.

Despite the hype surrounding GLP-1 receptor agonists, a significant proportion of patients discontinue treatment after a few months, reducing the chances of long-term benefits.

A recent study out of Laval University finds many foods that are high in sodium and sugar on Canadian shelves are much cheaper than healthier, equivalent options.

Orforglipron, a GLP-1 receptor agonist in tablet form, has proven effective in treating obesity in a phase 3 trial, offering a potential alternative to injectable treatments like Wegovy and Ozempic.

Two Alberta pharmacists pursue paths to make weight-management a key part of their practice.